EP2047282A2 - Dispositif destiné au traitement d échantillons - Google Patents
Dispositif destiné au traitement d échantillonsInfo
- Publication number
- EP2047282A2 EP2047282A2 EP07786396A EP07786396A EP2047282A2 EP 2047282 A2 EP2047282 A2 EP 2047282A2 EP 07786396 A EP07786396 A EP 07786396A EP 07786396 A EP07786396 A EP 07786396A EP 2047282 A2 EP2047282 A2 EP 2047282A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- module
- sample
- unit
- vessels
- vessel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000012545 processing Methods 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 184
- 230000008569 process Effects 0.000 claims abstract description 169
- 239000000523 sample Substances 0.000 claims abstract description 159
- 230000003750 conditioning effect Effects 0.000 claims abstract description 37
- 239000012472 biological sample Substances 0.000 claims abstract description 27
- 238000002360 preparation method Methods 0.000 claims abstract description 23
- 238000006243 chemical reaction Methods 0.000 claims description 61
- 238000004458 analytical method Methods 0.000 claims description 37
- 238000003860 storage Methods 0.000 claims description 36
- 230000003321 amplification Effects 0.000 claims description 29
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 29
- 238000012546 transfer Methods 0.000 claims description 29
- 238000000605 extraction Methods 0.000 claims description 23
- 230000009089 cytolysis Effects 0.000 claims description 22
- 238000007885 magnetic separation Methods 0.000 claims description 12
- 238000011144 upstream manufacturing Methods 0.000 claims description 10
- 238000004891 communication Methods 0.000 claims description 6
- 238000005516 engineering process Methods 0.000 claims description 6
- 230000001143 conditioned effect Effects 0.000 claims description 4
- 238000002604 ultrasonography Methods 0.000 claims description 4
- 238000011068 loading method Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 2
- 239000012491 analyte Substances 0.000 abstract description 21
- 230000000977 initiatory effect Effects 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 description 25
- 239000002245 particle Substances 0.000 description 20
- 239000011159 matrix material Substances 0.000 description 19
- 238000003752 polymerase chain reaction Methods 0.000 description 19
- 102000039446 nucleic acids Human genes 0.000 description 18
- 108020004707 nucleic acids Proteins 0.000 description 18
- 150000007523 nucleic acids Chemical class 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 16
- 239000000243 solution Substances 0.000 description 14
- 238000001179 sorption measurement Methods 0.000 description 14
- 239000000470 constituent Substances 0.000 description 12
- 238000010828 elution Methods 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 10
- 239000007788 liquid Substances 0.000 description 9
- 238000012423 maintenance Methods 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 8
- 102000053602 DNA Human genes 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 238000010606 normalization Methods 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 229920002477 rna polymer Polymers 0.000 description 7
- 108020004459 Small interfering RNA Proteins 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 108091005461 Nucleic proteins Proteins 0.000 description 3
- 102000015636 Oligopeptides Human genes 0.000 description 3
- 108010038807 Oligopeptides Proteins 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000010924 continuous production Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 239000011859 microparticle Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108090000994 Catalytic RNA Proteins 0.000 description 2
- 102000053642 Catalytic RNA Human genes 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 108091093037 Peptide nucleic acid Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 108020004688 Small Nuclear RNA Proteins 0.000 description 2
- 102000039471 Small Nuclear RNA Human genes 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000003795 desorption Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 238000007834 ligase chain reaction Methods 0.000 description 2
- 230000002934 lysing effect Effects 0.000 description 2
- 239000006249 magnetic particle Substances 0.000 description 2
- 238000010297 mechanical methods and process Methods 0.000 description 2
- 230000005226 mechanical processes and functions Effects 0.000 description 2
- 108091070501 miRNA Proteins 0.000 description 2
- 239000002679 microRNA Substances 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108091092562 ribozyme Proteins 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
- 241000796533 Arna Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229930182476 C-glycoside Natural products 0.000 description 1
- 150000000700 C-glycosides Chemical class 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229930182474 N-glycoside Natural products 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- -1 RNA Chemical class 0.000 description 1
- 102000000574 RNA-Induced Silencing Complex Human genes 0.000 description 1
- 108010016790 RNA-Induced Silencing Complex Proteins 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- 241000726445 Viroids Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001218 confocal laser scanning microscopy Methods 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 238000013412 genome amplification Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000012432 intermediate storage Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000001001 laser micro-dissection Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000010208 microarray analysis Methods 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 102000035118 modified proteins Human genes 0.000 description 1
- 108091005573 modified proteins Proteins 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000000399 optical microscopy Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000011112 process operation Methods 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 239000012521 purified sample Substances 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000004171 remote diagnosis Methods 0.000 description 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000003196 serial analysis of gene expression Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000000672 surface-enhanced laser desorption--ionisation Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- KUAZQDVKQLNFPE-UHFFFAOYSA-N thiram Chemical compound CN(C)C(=S)SSC(=S)N(C)C KUAZQDVKQLNFPE-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00584—Control arrangements for automatic analysers
- G01N35/00594—Quality control, including calibration or testing of components of the analyser
- G01N35/00712—Automatic status testing, e.g. at start-up or periodic
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00584—Control arrangements for automatic analysers
- G01N35/00722—Communications; Identification
- G01N35/00871—Communications between instruments or with remote terminals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N2035/00178—Special arrangements of analysers
- G01N2035/00326—Analysers with modular structure
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/02—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations
- G01N35/04—Details of the conveyor system
- G01N2035/0474—Details of actuating means for conveyors or pipettes
- G01N2035/0491—Position sensing, encoding; closed-loop control
- G01N2035/0493—Locating samples; identifying different tube sizes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00584—Control arrangements for automatic analysers
- G01N35/00594—Quality control, including calibration or testing of components of the analyser
- G01N35/00613—Quality control
- G01N35/00663—Quality control of consumables
Landscapes
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Quality & Reliability (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Sampling And Sample Adjustment (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07786396.7A EP2047282B1 (fr) | 2006-07-28 | 2007-07-27 | Dispositif destiné au traitement d'échantillons |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83419506P | 2006-07-28 | 2006-07-28 | |
EP06015812A EP1882948A2 (fr) | 2006-07-28 | 2006-07-28 | Dispositif destiné au traitement d échantillons |
EP07786396.7A EP2047282B1 (fr) | 2006-07-28 | 2007-07-27 | Dispositif destiné au traitement d'échantillons |
PCT/EP2007/006684 WO2008012104A2 (fr) | 2006-07-28 | 2007-07-27 | Dispositif de traitement d'échantillons |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2047282A2 true EP2047282A2 (fr) | 2009-04-15 |
EP2047282B1 EP2047282B1 (fr) | 2014-05-07 |
Family
ID=38596322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07786396.7A Active EP2047282B1 (fr) | 2006-07-28 | 2007-07-27 | Dispositif destiné au traitement d'échantillons |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP2047282B1 (fr) |
JP (2) | JP2009544955A (fr) |
AU (1) | AU2007278425B2 (fr) |
CA (1) | CA2658533C (fr) |
WO (1) | WO2008012104A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2990804A1 (fr) * | 2014-08-29 | 2016-03-02 | Sysmex Corporation | Système de test |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2261650A3 (fr) | 2004-09-15 | 2011-07-06 | IntegenX Inc. | Dispositifs microfluidiques |
JP5063616B2 (ja) | 2006-02-03 | 2012-10-31 | インテジェニックス インコーポレイテッド | マイクロ流体デバイス |
WO2008115626A2 (fr) | 2007-02-05 | 2008-09-25 | Microchip Biotechnologies, Inc. | Dispositifs, systèmes et applications microfluidiques et nanofluidiques |
EP2234916A4 (fr) | 2008-01-22 | 2016-08-10 | Integenx Inc | Système de préparation d échantillon universel et utilisation dans un système d analyse intégré |
CN102341691A (zh) | 2008-12-31 | 2012-02-01 | 尹特根埃克斯有限公司 | 具有微流体芯片的仪器 |
EP2438154A1 (fr) | 2009-06-02 | 2012-04-11 | Integenx Inc. | Dispositif fluidique a soupapes a membrane |
KR20120031218A (ko) | 2009-06-05 | 2012-03-30 | 인터젠엑스 인크. | 만능 샘플 제조 시스템 및 집적 분석 시스템에서의 사용 |
GB2472236A (en) * | 2009-07-29 | 2011-02-02 | Iti Scotland Ltd | Apparatus for analysing microfluidic devices |
US8584703B2 (en) | 2009-12-01 | 2013-11-19 | Integenx Inc. | Device with diaphragm valve |
JP5819617B2 (ja) | 2010-03-04 | 2015-11-24 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 分析器のハードウェア構成 |
EP2629098B1 (fr) | 2010-03-04 | 2017-04-19 | F. Hoffmann-La Roche AG | Horloge de flux de travail entre les modules |
US8512538B2 (en) | 2010-05-28 | 2013-08-20 | Integenx Inc. | Capillary electrophoresis device |
WO2012013733A1 (fr) | 2010-07-29 | 2012-02-02 | F. Hoffmann - La Roche Ag | Préparation d'échantillons génériques |
WO2012024658A2 (fr) | 2010-08-20 | 2012-02-23 | IntegenX, Inc. | Système d'analyse intégrée |
WO2012024657A1 (fr) | 2010-08-20 | 2012-02-23 | IntegenX, Inc. | Dispositifs microfluidiques pourvus de soupapes à diaphragme mécaniquement scellées |
JP5690543B2 (ja) * | 2010-10-05 | 2015-03-25 | 株式会社日立ハイテクノロジーズ | 検体検査自動化装置,自動分析装置およびシステム |
CN103370616B (zh) | 2010-10-29 | 2017-03-29 | 恩姆菲舍尔科技公司 | 用于样品制备和分析的自动化系统及方法 |
US9164114B2 (en) * | 2011-04-19 | 2015-10-20 | Roche Molecular Systems, Inc. | Supply unit for continuous loading |
JP5789441B2 (ja) * | 2011-08-01 | 2015-10-07 | 株式会社日立ハイテクノロジーズ | 遺伝子検査システム |
US20150136604A1 (en) | 2011-10-21 | 2015-05-21 | Integenx Inc. | Sample preparation, processing and analysis systems |
US10865440B2 (en) | 2011-10-21 | 2020-12-15 | IntegenX, Inc. | Sample preparation, processing and analysis systems |
AU2013251488A1 (en) * | 2012-04-27 | 2014-11-13 | Cepheid | Apparatus with heterogeneous processing modules |
EP2857842B1 (fr) | 2013-10-07 | 2022-09-21 | Eppendorf SE | Commande d'accès pour un appareil de laboratoire, appareil de laboratoire avec commande d'accès et procédé de traitement d'échantillons de laboratoire commandé par un appareil |
ES2877222T3 (es) | 2013-10-07 | 2021-11-16 | Eppendorf Ag | Instrumento de laboratorio para el procesamiento controlado por instrumento de al menos una muestra de laboratorio, y un método para configurar el instrumento de laboratorio mediante el sistema de control de configuración |
EP2857844B1 (fr) | 2013-10-07 | 2021-12-01 | Eppendorf AG | Appareil de laboratoire, système et procédé de traitement commandé par un appareil d'au moins un échantillon de laboratoire en utilisant au moins un article de consommation |
EP2857843A1 (fr) * | 2013-10-07 | 2015-04-08 | Eppendorf Ag | Système présentant au moins deux appareils de laboratoire pour le traitement commandé par un appareil d'une tâche relative à une pièce dans un processus de traitement contenant des traitements d'au moins un échantillon de laboratoire, appareil de laboratoire et procédé |
WO2015073999A1 (fr) | 2013-11-18 | 2015-05-21 | Integenx Inc. | Cartouches et instruments pour l'analyse d'échantillons |
AU2014384731B2 (en) | 2014-02-28 | 2017-12-14 | Gen-Probe Incorporated | Method of isolating nucleic acid from specimens in liquid-based cytology preservatives containing formaldehyde |
GB2528344B (en) | 2014-02-28 | 2018-10-31 | Gen Probe Inc | Method of isolating nucleic acid from specimens in liquid-based cytology preservatives containing formaldehyde |
US9771571B2 (en) | 2014-02-28 | 2017-09-26 | Gen-Probe Incorporated | Method of isolating nucleic acid from specimens in liquid-based cytology preservatives containing formaldehyde |
US9771572B2 (en) | 2014-02-28 | 2017-09-26 | Gen-Probe Incorporated | Method of isolating nucleic acid from specimens in liquid-based cytology preservatives containing formaldehyde |
US10208332B2 (en) | 2014-05-21 | 2019-02-19 | Integenx Inc. | Fluidic cartridge with valve mechanism |
EP3209410A4 (fr) | 2014-10-22 | 2018-05-02 | IntegenX Inc. | Systèmes et méthodes de préparation, de traitement et d'analyse d'échantillon |
JP6937116B2 (ja) | 2016-12-15 | 2021-09-22 | シスメックス株式会社 | 前処理装置及び前処理方法 |
CN110494754B (zh) * | 2017-03-29 | 2024-01-26 | 环球生物研究株式会社 | 被检测体处理测量系统 |
CN113383238A (zh) * | 2018-08-29 | 2021-09-10 | 株式会社日立高新技术 | 自动分析装置 |
US11331660B2 (en) * | 2019-01-04 | 2022-05-17 | Funai Electric Co. Ltd. | Digital dispense system |
JP7317522B2 (ja) * | 2019-03-06 | 2023-07-31 | マルヤス工業株式会社 | 自動ろ過装置 |
CN110865018B (zh) * | 2019-08-08 | 2023-03-28 | 上海交通大学医学院附属新华医院 | 一种样品后处理系统、设备和方法 |
EP3789772A1 (fr) * | 2019-09-05 | 2021-03-10 | Roche Diagnostics GmbH | Procédé de détermination d'une position de crémaillère sur une unité de placement de crémaillère d'un système de manipulation de laboratoire et système de manipulation de laboratoire |
JP7415908B2 (ja) | 2020-12-15 | 2024-01-17 | 株式会社島津製作所 | 試料前処理装置 |
CN114574323B (zh) * | 2022-03-31 | 2023-04-07 | 江苏莱尔生物医药科技有限公司 | 一种细胞分离装置 |
WO2023227985A1 (fr) * | 2022-05-27 | 2023-11-30 | 3M Innovative Properties Company | Dispositif de collecte d'échantillons d'agents pathogènes |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5428470A (en) * | 1992-07-17 | 1995-06-27 | Beckman Instruments, Inc. | Modular system and method for an automatic analyzer |
JP2947146B2 (ja) * | 1995-09-29 | 1999-09-13 | 株式会社島津製作所 | オ−トサンプラ |
JP3032159B2 (ja) * | 1996-09-24 | 2000-04-10 | 株式会社日立製作所 | 分析システム |
JPH11304812A (ja) * | 1998-04-20 | 1999-11-05 | Hitachi Ltd | 検体処理システム |
ES2322859T3 (es) * | 1998-05-01 | 2009-06-30 | Gen-Probe Incorporated | Analizador de diagnostico automatizado. |
JP4101466B2 (ja) * | 1998-07-27 | 2008-06-18 | 株式会社日立製作所 | 生体サンプルの分析装置 |
WO2000060362A1 (fr) * | 1999-04-08 | 2000-10-12 | Chung Chang Young | Appareil de preparation et d'analyse rapides d'acides nucleiques |
JP3587124B2 (ja) * | 2000-04-12 | 2004-11-10 | 松下電器産業株式会社 | 分注装置および分注方法 |
US20040241828A1 (en) * | 2001-07-24 | 2004-12-02 | Marie-Christine Huau | Automated process for detecting pathogenic organisms in water |
US6881579B2 (en) * | 2001-07-30 | 2005-04-19 | Agilent Technologies, Inc. | Sample processing apparatus and methods |
JP3771840B2 (ja) * | 2001-12-27 | 2006-04-26 | アロカ株式会社 | マイクロプレート搬送装置 |
US7718072B2 (en) * | 2002-04-26 | 2010-05-18 | Abbott Laboratories | Structure and method for handling magnetic particles in biological assays |
JP2004166555A (ja) * | 2002-11-19 | 2004-06-17 | Sanyo Electric Co Ltd | インキュベータ |
US7013198B2 (en) * | 2002-12-16 | 2006-03-14 | Thermo Crs Ltd. | Robotic carousel workstation |
DE10331254B4 (de) * | 2003-07-10 | 2006-05-04 | Chemagen Biopolymer-Technologie Aktiengesellschaft | Vorrichtung und Verfahren zum Abtrennen von magnetischen oder magnetisierbaren Partikeln aus einer Flüssigkeit |
-
2007
- 2007-07-27 AU AU2007278425A patent/AU2007278425B2/en active Active
- 2007-07-27 WO PCT/EP2007/006684 patent/WO2008012104A2/fr active Application Filing
- 2007-07-27 JP JP2009521171A patent/JP2009544955A/ja active Pending
- 2007-07-27 CA CA2658533A patent/CA2658533C/fr active Active
- 2007-07-27 EP EP07786396.7A patent/EP2047282B1/fr active Active
-
2013
- 2013-05-08 JP JP2013098383A patent/JP5886787B2/ja active Active
Non-Patent Citations (1)
Title |
---|
See references of WO2008012104A2 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2990804A1 (fr) * | 2014-08-29 | 2016-03-02 | Sysmex Corporation | Système de test |
US11397190B2 (en) | 2014-08-29 | 2022-07-26 | Sysmex Corporation | Test system |
Also Published As
Publication number | Publication date |
---|---|
WO2008012104A2 (fr) | 2008-01-31 |
JP5886787B2 (ja) | 2016-03-16 |
EP2047282B1 (fr) | 2014-05-07 |
CA2658533A1 (fr) | 2008-01-31 |
JP2009544955A (ja) | 2009-12-17 |
JP2013172736A (ja) | 2013-09-05 |
AU2007278425A1 (en) | 2008-01-31 |
WO2008012104A3 (fr) | 2008-05-29 |
CA2658533C (fr) | 2016-03-15 |
AU2007278425B2 (en) | 2011-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2658533C (fr) | Dispositif de traitement d'echantillons | |
US10458998B2 (en) | Device for processing samples | |
AU785010B2 (en) | System and method for manipulating magnetically responsive particles in fluid samples to collect DNA or RNA from a sample | |
CN108103057B (zh) | 用于纯化核酸的方法和试剂盒 | |
EP1282469B1 (fr) | Systeme et procede de manipulation de particules magnetiquement sensibles dans des echantillons de fluide pour extraire l'adn ou l'arn d'un echantillon | |
US9028777B2 (en) | Automated cellular material preparation | |
JP5078955B2 (ja) | 分析のために流体を処理する装置および方法 | |
US8685322B2 (en) | Apparatus and method for the purification of biomolecules | |
EP2192186B1 (fr) | Système et précédé pour l'extraction automatisée des acides nucléiques | |
US20030203491A1 (en) | Gravitational flow purification system | |
WO2007050327A2 (fr) | Appareil compact, compositions et procedes pour la purification d'acides nucleiques | |
JP2010127941A5 (fr) | ||
US20150152405A1 (en) | Suspension container for binding particles for the isolation of biological material | |
US8175810B2 (en) | Sample processing apparatus and sample processing method | |
EP3759244B1 (fr) | Procédé et système de manipulation de particules à haut débit en utilisant des champs magnétiques | |
EP2423688B1 (fr) | Conteneur de suspension pour des particules de liaison pour l'isolation de matériel biologique | |
CN219689719U (zh) | 一种核酸提取扩增一体化系统及试剂盒 | |
Cardona et al. | Design considerations in high-throughput automation for biotechnology | |
EP2535712A1 (fr) | Système analytique pour la préparation d'un matériau biologique | |
Wells et al. | Automation of Sample | |
Wells et al. | Automation of sample preparation for genomics.(Sample Prep Perspectives). |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20090211 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK RS |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: FRIEDERICHS, ULF Inventor name: WALDER, BRUNO Inventor name: AESCHBACHER, JUERG Inventor name: WIDLER, PATRICK Inventor name: ALFREDSSON, MAGNUS Inventor name: BUETZER, AXEL Inventor name: FARNER, SAMUEL Inventor name: DEUTSCHMANN, THOMAS Inventor name: LUTZE, KONSTANTIN |
|
17Q | First examination report despatched |
Effective date: 20090723 |
|
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20130415 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 35/04 20060101ALI20131008BHEP Ipc: G01N 35/00 20060101AFI20131008BHEP |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20140103 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 667075 Country of ref document: AT Kind code of ref document: T Effective date: 20140515 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602007036558 Country of ref document: DE Effective date: 20140618 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 667075 Country of ref document: AT Kind code of ref document: T Effective date: 20140507 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20140507 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140507 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140507 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140507 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140808 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140907 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140507 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140507 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140507 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140507 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140507 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140908 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140507 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140507 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140507 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140507 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140507 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140507 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602007036558 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140727 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140507 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20150210 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602007036558 Country of ref document: DE Effective date: 20150210 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140507 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140727 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140507 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140507 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140507 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 10 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140507 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20070727 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20230724 Year of fee payment: 17 Ref country code: GB Payment date: 20230720 Year of fee payment: 17 Ref country code: CH Payment date: 20230801 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20230725 Year of fee payment: 17 Ref country code: DE Payment date: 20230719 Year of fee payment: 17 |